HADLIMA 40 MG SOL INJ CT 2 SER PREENCH VD TRANS X 0,8 ML
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1592100040038 -
GGREM
569723010000607 -
Código de barras
7898994611554
O que a fonte publica
- Detentor do registro
- SAMSUNG BIOEPIS BR PHARMACEUTICAL LTDA.
- Princípios ativos
- ADALIMUMABE
- Embalagem
- 40 MG SOL INJ CT 2 SER PREENCH VD TRANS X 0,8 ML
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Biológico
- Classe terapêutica
- L4B - PRODUTOS ANTI-TNF( FATOR DE NECROSE TUMORAL)
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "HADLIMA 40 MG SOL INJ CT 2 SER PREENCH VD TRANS X 0,8 ML",
"holder": "SAMSUNG BIOEPIS BR PHARMACEUTICAL LTDA.",
"stripe": "Tarja Vermelha",
"barcodes": [
"7898994611554"
],
"confaz87": true,
"currency": "BRL",
"marketed": null,
"ggremCode": "569723010000607",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "24.563.776/0001-88",
"priceRegime": "Regulado",
"productName": "HADLIMA",
"productType": "Biológico",
"hospitalOnly": false,
"presentation": "40 MG SOL INJ CT 2 SER PREENCH VD TRANS X 0,8 ML",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "2641.09",
"icms-12": "3001.24",
"icms-17": "3182.04",
"icms-18": "3220.84",
"icms-19": "3260.61",
"icms-20": "3301.36",
"icms-21": "3343.15",
"icms-22": "3386.01",
"icms-23": "3429.99",
"icms-17.5": "3201.32",
"icms-19.5": "3280.86",
"icms-20.5": "3322.13",
"icms-22.5": "3407.86",
"icms-12-alc": "2965.22",
"icms-17-alc": "3143.85",
"icms-18-alc": "3182.19",
"icms-19-alc": "3221.48",
"icms-20-alc": "3261.74",
"icms-21-alc": "3303.03",
"icms-22-alc": "3345.38",
"icms-23-alc": "3388.82",
"withoutTaxes": "2609.40",
"icms-17.5-alc": "3162.90",
"icms-19.5-alc": "3241.49",
"icms-20.5-alc": "3282.26",
"icms-22.5-alc": "3366.96"
},
"pisCofinsList": "Positiva",
"substanceText": "ADALIMUMABE",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "3640.47",
"icms-12": "4136.90",
"icms-17": "4386.11",
"icms-18": "4439.59",
"icms-19": "4494.41",
"icms-20": "4550.58",
"icms-21": "4608.18",
"icms-22": "4667.26",
"icms-23": "4727.88",
"icms-17.5": "4412.69",
"icms-19.5": "4522.32",
"icms-20.5": "4579.21",
"icms-22.5": "4697.38",
"icms-12-alc": "4099.24",
"icms-17-alc": "4346.19",
"icms-18-alc": "4399.19",
"icms-19-alc": "4453.51",
"icms-20-alc": "4509.16",
"icms-21-alc": "4566.25",
"icms-22-alc": "4624.79",
"icms-23-alc": "4684.84",
"withoutTaxes": "3607.34",
"icms-17.5-alc": "4372.52",
"icms-19.5-alc": "4481.17",
"icms-20.5-alc": "4537.53",
"icms-22.5-alc": "4654.62"
},
"invalidBarcodes": [],
"activeSubstances": [
"ADALIMUMABE"
],
"therapeuticClass": "L4B - PRODUTOS ANTI-TNF( FATOR DE NECROSE TUMORAL)",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1592100040038",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "L4B",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:569723010000607"